Nektar Therapeutics
Closed
59.38 3.09
Overview
Share price change
24h
Min
56.88
Max
60.91
Income | 4.3M -41M |
|---|---|
Sales | -730K 10M |
EPS | -1.23 |
Profit margin | -400.967 |
Employees | 63 |
EBITDA | -5.5M -42M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +128.22% upside |
Next Earnings | 5 lis 2026 |
|---|
Market Cap | -247M 2.3B |
|---|---|
Previous open | 56.29 |
Previous close | 59.38 |
Nektar Therapeutics Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
Nektar Therapeutics Forecast
Price Target
By TipRanks
128.22% upside
12 Months Forecast
Average 139.143 USD 128.22%
High 192 USD
Low 50 USD
Based on 9 Wall Street analysts offering 12 month price targets forNektar Therapeutics - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$